A comparison of the efficacy and duration of action of telmisartan, amlodipine and ramipril in patients with confirmed ambulatory hypertension

Blood Pressure Monitoring

Volumn 9, Issue 5, 2004, Pages 231-236

  Poirier, Luc ^a   De Champlain, Jacques ^b   Larochelle, Pierre ^b   Lamarre Cliche, Maxime ^b   Lacourcière, Yves ^a  

^a LAVAL UNIVERSITY   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Ambulatory blood pressure monitoring; Angiotensin II receptor blocker; Angiotensin converting enzyme inhibitor; Calcium channel blocker

Indexed keywords

AMLODIPINE; RAMIPRIL; RENIN; TELMISARTAN;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

EID: 12344313951     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126097-200410000-00001     Document Type: Article

References (15)

1. Laragh JH. Historical perspective on renin system blockade in the treatment of hypertension. Am J Hypertens 1992; 5(12 Pt 2):207S-208S.
2. 1 receptor antagonist telmisartan in patients with mild-to-moderate hypertension. Adv Ther 1998; 15:206-217.
3. Maillon JM, Siché JP, Lacourcière Y. ABPM comparison of antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension. J Hum Hypertens 1999; 13:657-664.
4. Lacourcière Y, and the Telmisartan Cough Study Group. The incidence of cough: a comparison of lisinopril, placebo and telmisartan, a novel angiotensin II antagonist. Int J Clin Pract 1999; 53:99-103.
5. Heber ME, Brigden G, Al-Khawaja I, Rafterry EB. 24-hour blood pressure control with the once daily calcium antagonist, amlodipine. Br J Clin Pharmacol 1989; 27:359-365.
6. Lacourcière Y, Poirier L, Lefebvre J, Archambault F, Cléroux J, Boileau G. Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension. Am J Hypertens 1995; 8:1154-1159.
7. Lacourcière Y, Lenis J, Orchard R, Lewanczuk R, Houde M, Pesant Y, et al. A comparison of the efficacies and durations of action of the angiotensin II receptor blocker telmisartan and amlodipine. Blood Press Monit 1998; 3:295-302.
8. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyrne inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction and stroke in high-risk patients. N Engl J Med 2000; 342:145-153.
9. Fox KM, and the EUROPA Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo controlled, multicentre trial. Lancet 2003; 362:782-788.
10. White WB. Methods of blood pressure determinations to assess antihypertensive therapy. Are casual measurements enough? Clin Pharmacol Ther 1989; 45:581-586.
11. White WB. Advances in ambulatory blood pressure monitoring for the evaluation of antihypertensive therapy in research and practice. In: White WB (editor): Blood pressure monitoring in cardiovascular medicine and therapies. Totowa, NJ: Human Press; 2001, pp. 273-298.
12. Myers MG, Reeves RA. White coat phenomenon in patients receiving antihypertensive therapy. Am J Hypertens 1991; 4:844-849.
13. Svensson P, de Faire J, Sleight P, Yusuf S, Ostergren J. Comparative effects of ramipril on ambulatory and office blood pressure: a HOPE substudy. Hypertension 2001; 38(Suppl):E28-E32.
14. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-hour blood pressure: the Ohasama study. J Hypertens 2002; 20:2183-2189.
15. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003; 107:1401-1406.